Title Ascorbic acid for the common cold. A prophylactic and therapeutic trial.
Author Karlowski, T R; Chalmers, T C; Frenkel, L D; Kapikian, A Z; Lewis, T L; Lynch, J M
Journal JAMA Publication Year/Month 1975-Mar
PMID 163386 PMCID -N/A-

Three hundred eleven employees of the National Institutes of Health volunteered to take 1 gm of ascorbic acid or lactose placebo in capsules three times a day for nine months. At the onset of a cold, the volunteers were given an additional 3 gm daily of either a placebo or ascorbic acid. One hundred ninety volunteers completed the study. Dropouts were defined as those who missed at least one month of drug ingestion. They represented 44% of the placebo group and 34% of those taking ascorbic acid. Analysis of these data showed that ascorbic acid had at best only a minor influence on the duration and severity of colds, and that the effects demonstrated might be explained equally well by a break in the double blind.

  • Copyright © 2023
    National Institute of Pathogen Biology, CAMS & PUMC, Bejing, China
    All rights reserved.